4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000071
EVP, Chf Clinical Develop Ofcr sold 9,302 shares at $75.59 ($703,138)
- EVP, Chf Clinical Develop Ofcr acquired 21,685 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 1 in the form | +21,685 | 73,192 | D | ||
| 2026-01-16 | Sale : show line 2 in the form | −9,302 | $75.59 | $703,138 | 63,890 | D |
| Open-market sales · 9,302 sh · avg $75.59 · $703,138 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +25,800 | 91,237 | D |
| 2026-01-15 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −21,685 | 39,251 | D |
| 2026-01-15 | Grant or award : show line 5 in the form Restricted Stock Unit | +9,675 | 48,926 | D |
Loading xslF345X05/edgardoc.xml…